.avif)
.avif)
Amicus Therapeutics Email Format
Biotechnology Research
・
501-1,000 employees
・
Princeton, NJ, USA
Amicus Therapeutics is a biotechnology company focused on developing therapies for rare genetic diseases, now part of BioMarin Pharmaceutical Inc.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@amicusrx.com
Company Overview
Industry
Biotechnology Research
Founded
2002
Headquarters
Princeton, NJ, USA
Revenue
$500M-$1B
FUNDING Stage
Acquired
Website
Key Executives
Bradley Campbell (President and Chief Executive Officer), Simon Harford (Chief Financial Officer), Pat O'Sullivan (Chief Technical Operations Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Amicus Therapeutics?
Amicus Therapeutics uses the firstinitiallast format, so Jane Smith would be jsmith@amicusrx.com.
What rare disease products does Amicus Therapeutics currently have on the market?
Amicus Therapeutics markets Galafold (migalastat) for Fabry disease and the two-component therapy Pombiliti plus Opfolda (cipaglucosidase alfa-atga with miglustat) for late-onset Pompe disease, with both treatments approved across multiple countries including the U.S., EU, U.K., and Japan.
How did BioMarin's 2026 acquisition affect Amicus Therapeutics?
BioMarin Pharmaceutical completed its acquisition of Amicus Therapeutics in April 2026 for approximately $4.8 billion in an all-cash deal, adding Galafold and the Pombiliti plus Opfolda regimen to BioMarin's commercial rare disease portfolio.
Who leads Amicus Therapeutics as its chief executive?
Bradley Campbell serves as President and Chief Executive Officer of Amicus Therapeutics, based out of the company's headquarters in Princeton, NJ. He testified before the U.S. Senate Special Committee in support of Rare Disease Week in 2026.
Can Clay help me find and verify contact details for Amicus Therapeutics employees?
Yes, Clay can help you build and enrich a contact list for Amicus Therapeutics by verifying email addresses using the firstinitiallast@amicusrx.com format and surfacing specific employees by role, team, or seniority across the company's roughly 625-person workforce.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating